Using Social Media Big Data to Combat Prescription Drug Crisis

Researchers at Dartmouth, Stanford University, and IBM Research, conducted a critical review of existing literature to determine whether social media big data can be used to understand communication and behavioral patterns related to prescription drug abuse. Their study found that with proper research methods and attention to privacy and ethical issues, social media big data can reveal important information concerning drug abuse, such as user-reported side effects, drug cravings, emotional states, and risky behaviors.

Their work, "Scaling Up Prescription Drug Abuse and Addiction Research Through Social Media Big Data," is reported in the Journal of Medical Internet Research .

Prescription drug addiction is a well-known nationwide problem. Many people who are unable to get help for their addiction seek out peer support groups on Facebook or other social media platforms to share stories about their experiences and also provide social peer-based support.

Lead author, Sunny Jung Kim, PhD, an e-health communication scholar in the departments of biomedical data science and psychiatry at Dartmouth's Geisel School of Medicine, says that because we are prolific consumers of social media, which is not limited to geography - globally, people spend more than two hours every day on social media platforms generating vast amounts of big data about our personal communications and activities - we can use these platforms to enhance public health communication strategies to help people on a large scale.

"Harnessing social media platforms and data can provide insight into important novel discoveries of collective public health risk behavior, a better understanding of peoples' struggles with addiction, and their process of recovery," Kim says. "I started this project because there were few studies about why people use social networking sites to share unsolicited, highly personal information about their drug use, nor about the psychological effects or consequences of this type of user-generated communication."

Co-author Jeffrey Hancock, PhD, a professor in the department of communication and the director of computational social science at Stanford University, says, "Given the importance of this problem for the U.S. population, it's imperative that we understand how social media is playing a role and how it can be part of the solution."

Based on their findings, the researchers designed an evidence-based, multi-level framework to inform future social media-based substance use prevention and recovery intervention programs.

"Our review and typology suggests that social media big data and platforms can be a tremendous resource for monitoring and intervening on behalf of people with drug addiction and abuse problems," Kim says.

Kim SJ, Marsch LA, Hancock JT, Das AK.
Scaling Up Research on Drug Abuse and Addiction Through Social Media Big Data.
J Med Internet Res 2017;19(10):e353. doi: 10.2196/jmir.6426.

Most Popular Now

Open Call SC1-DTH-01-2019: Big Data and …

Currently available methods and strategies for diagnosis and treatment of cancer help clinicians continuously improve quality of care and prevent cancer deaths in the population. Accurate risk assessment, availability of...

Cerner Selected for NHS Framework to Sup…

Integrated Care Systems (ICS) and Sustainability and Transformation Partnerships (STPs) aim to deliver the best possible quality of health and care, shift to value-based care and proactively improve outcomes for...

Brainlab and Magic Leap Partner in Digit…

Brainlab has announced a strategic development partnership with Florida-based Magic Leap, a developer of proprietary spatial computing solutions that help users enrich their real world experience by integrating digital content...

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Satellites...

Whole-Brain Connectome Maps Teach Artifi…

Medical University of South Carolina (MUSC) neurologists have developed a new method based on artificial intelligence that may eventually help both patients and doctors weigh the pros and cons of...

Oxehealth Secures World-First Accreditat…

The British Standards Institute (BSI) has accredited Oxehealth's vital signs measurement software as a Class IIa medical device in Europe. This is the first time that software enabling a digital...

MEDICA 2018: The Starting Block for Many…

12 - 15 November 2018, Düsseldorf, Germany. MEDICA, the world’s leading medical trade fair in Düsseldorf which attracts over 5,000 exhibitors from around 70 countries, is becoming an even bigger hotspot...

MEDICA 2018 Presents the Future of Medic…

12 - 15 November 2018, Düsseldorf, Germany. Artificial intelligence, Big Data or IoT (Internet of Things) - we would be hard pressed to find a sector that doesn’t have these terms...

Artificial Intelligence for Health: ITU …

The ITU Focus Group on 'AI for Health' (FG-AI4H), created in collaboration with the World Health Organization (WHO), has issued a Call for Proposals to identify compelling use cases of...

Siemens Healthineers and STORZ MEDICAL P…

On the occasion of the 70th annual congress of the German Society for Urology, DGU, Siemens Healthineers and STORZ MEDICAL have announced plans to enter into a sales partnership agreement...

Spinal Cord Stimulation, Physical Therap…

Spinal cord stimulation and physical therapy have helped a man paralyzed since 2013 regain his ability to stand and walk with assistance. The results, achieved in a research collaboration between...

Sandoz Healthcare Access Challenge #Sand…

Sandoz, the Novartis generics and biosimilars division, today announces the launch of the second Sandoz Healthcare Access Challenge (HACk). The #SandozHACk is a global competition that invites entrepreneurs and innovators...